Manur Multi Specialty Hospital successfully treats 14-year-old boy with Guillain-Barre Syndrome, AMSAN, and breathing issues.

Cantargia (Cantargia AB); today announced new clinical results from two nadunolimab combination therapy trials in 54 patients. Positive signals of efficacy were documented in the key areas of ...

The complement inhibitors market is gaining momentum due to the rising recognition of the complement system's role in driving rare and chronic diseases, such as paroxysmal nocturnal hemoglobinuria ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be ...

GenSight Biologics' lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and ...

Injury to the eye can also cause sudden vision loss, said Dr Vinit Banga, director of neurology and head of neuro ...

Two decades ago, when two genetic mutations were discovered in Asia that gave scientists a better idea of how pain sensations ...

The recall was initiated on October 10 and is ongoing. “Healthcare professionals can educate patients about alternative ...

In today’s 2024 modern era, many people are experiencing constant foot discomfort and pain. Whether it is because of ...

For residents in North Houston and The Woodlands, relief from foot pain is within reach. Doctor's Inc. offers advanced, ...